30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

John Agwunobi

Track

Insider profile

Currently holds positions in Herbalife Nutrition Ltd and bluebird bio Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Co-President and Chief Health and Nutrition Officer Herbalife Nutrition Ltd May 1, 2018 -
Independent Director bluebird bio Inc June 8, 2017 -
Independent Director Magellan Health Inc Dec. 11, 2014 - May 1, 2019
John Agwunobi's trades of Ensign Group Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-22 2026-04-20
PlS Planned sale
86,050 -1.7%
337.32
US$92,413 		86,050 -1.7% 337.32 US$92,413
2026-04-20 2026-04-20
PrS Proposed sale
98,382
42.22
US$4,754,878 		98,382 42.22 US$4,754,878
2026-01-22 2026-01-21
PlS Planned sale
46,425 -35.4%
420.78
US$4,618,162 		46,425 -35.4% 420.78 US$4,618,162
2026-01-21 2026-01-21
PrS Proposed sale
146
178.31
US$26,033 		146 178.31 US$26,033
2026-01-22 2026-01-20
PlS Planned sale
246 -2.6%
179.82
US$44,236 		246 -2.6% 179.82 US$44,236
2026-01-20 2026-01-20
PrS Proposed sale
246
179.82
US$44,236 		246 179.82 US$44,236
2025-11-07 2025-11-06
PlS Planned sale
246 -2.7%
188.87
US$46,462 		246 -2.7% 188.87 US$46,462
2025-11-06 2025-11-06
PrS Proposed sale
246
188.87
US$46,462 		246 188.87 US$46,462
2024-05-02 2024-04-30
B Purchase
0 +0.0%
117.58
US$18 		0 +0.0% 117.58 US$18
2022-05-11 2022-05-10
PP Planned purchase
4,222 +3.2%
23.55
US$99,434 		4,222 +3.2% 23.55 US$99,434